Cargando…

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma

The most frequent liver tumor in children is hepatoblastoma (HB), which derives from embryonic parenchymal liver cells or hepatoblasts. Hepatocellular carcinoma (HCC), which rarely affects young people, causes one fourth of deaths due to cancer in adults. In contrast, HB usually has better prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marin, Jose J. G., Cives-Losada, Candela, Asensio, Maitane, Lozano, Elisa, Briz, Oscar, Macias, Rocio I. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468761/ https://www.ncbi.nlm.nih.gov/pubmed/30909445 http://dx.doi.org/10.3390/cancers11030407

Ejemplares similares

Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma
por: Marin, Jose J. G., et al.
Publicado: (2020)

Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020)

Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
por: Marin, Jose J. G., et al.
Publicado: (2022)

Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020)

Models for Understanding Resistance to Chemotherapy in Liver Cancer
por: Marin, Jose J. G., et al.
Publicado: (2019)

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
por: Rodríguez-Macías, Gabriela, et al.
Publicado: (2023)

Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of Resistance
por: Marin, Jose J. G., et al.
Publicado: (2021)

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
por: Lozano, Elisa, et al.
Publicado: (2018)

The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
por: Marin, Jose JG, et al.
Publicado: (2014)

Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1
por: Herraez, Elisa, et al.
Publicado: (2017)

Lactation during cholestasis: Role of ABC proteins in bile acid traffic across the mammary gland
por: Blazquez, Alba M. G., et al.
Publicado: (2017)

Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
por: Macias, Rocio I.R., et al.
Publicado: (2018)

Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment
por: Marin, Jose J.G., et al.
Publicado: (2020)

Impact of Alternative Splicing Variants on Liver Cancer Biology
por: Marin, Jose J. G., et al.
Publicado: (2021)

‘Teratoid’ Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma
por: Sergi, Consolato M., et al.
Publicado: (2022)

Role of the Plasma Membrane Transporter of Organic Cations OCT1 and Its Genetic Variants in Modern Liver Pharmacology
por: Lozano, Elisa, et al.
Publicado: (2013)

Hepatoblastoma : presentación de un caso clínico /
por: Mora Sarmiento, Laura
Publicado: (1988)

Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
por: Alisi, Anna, et al.
Publicado: (2013)

PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
por: Marayati, Raoud, et al.
Publicado: (2021)

Hepatoblastoma: when to screen?
por: O’Malley, Margaret, et al.
Publicado: (2011)

Hepatoblastoma with Precocious Puberty
por: Yhoshu, Enono, et al.
Publicado: (2019)

The Genetic Changes of Hepatoblastoma
por: Chen, Huitong, et al.
Publicado: (2021)

Perinatal risk factors for hepatoblastoma
por: Spector, L G, et al.
Publicado: (2008)

The Role of BH3-Mimetic Drugs in the Treatment of Pediatric Hepatoblastoma
por: Lieber, Justus, et al.
Publicado: (2015)

Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse
por: Brown, Anthony, et al.
Publicado: (2023)

The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma
por: Lu, Enzhou, et al.
Publicado: (2022)

Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
por: Peng, Wan‐Xin, et al.
Publicado: (2022)

Hepatoblastoma—The Evolution of Biology, Surgery, and Transplantation
por: Lim, Irene Isabel P., et al.
Publicado: (2018)

Smoking and hepatoblastoma: confounding by birth weight?
por: Spector, L G, et al.
Publicado: (2003)

Hepatoblastoma in Adult: Review of the Literature
por: Zheng, Ming Hua, et al.
Publicado: (2009)

Mesenchymal Hamartoma Mimicking Hepatoblastoma
por: Bahador, A., et al.
Publicado: (2014)

Unresectable hepatoblastoma: current perspectives
por: Trobaugh-Lotrario, Angela D, et al.
Publicado: (2017)

Two Cases of Hepatoblastoma in Adults
por: Ihssan, Elouarith, et al.
Publicado: (2022)

Teratoid Hepatoblastoma—Our Experience
por: Berklite, Lara, et al.
Publicado: (2022)

Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug Therapies
por: Rikhi, Rishi Raj, et al.
Publicado: (2016)

Systematic analysis of the molecular mechanism of microRNA-124 in hepatoblastoma cells
por: Wang, Guiming, et al.
Publicado: (2017)

The function of Piezo1 in hepatoblastoma metastasis and its potential transduction mechanism
por: Ye, Xiaoshuo, et al.
Publicado: (2022)

CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China
por: Huang, Junting, et al.
Publicado: (2020)

Pseudo-resistance to anticancer drugs
por: Davoli, Enrico, et al.
Publicado: (2022)

A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
por: Saltsman, James A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ht4ftiflc7phuj4h4fr7ttqo2